Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II
- PMID: 28003313
- PMCID: PMC5408981
- DOI: 10.1093/ijnp/pyw092
Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II
Comment on
-
Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder.Int J Neuropsychopharmacol. 2015 Sep 13;19(3):pyv107. doi: 10.1093/ijnp/pyv107. Int J Neuropsychopharmacol. 2015. PMID: 26371184 Free PMC article. Review. No abstract available.
-
Suicidal Risks in Report of Reports of Long-Term Treatment Trials for Major Depressive Disorder.Int J Neuropsychopharmacol. 2017 Mar 1;20(3):279-280. doi: 10.1093/ijnp/pyw084. Int J Neuropsychopharmacol. 2017. PMID: 27655729 Free PMC article. No abstract available.
References
-
- Baldessarini RJ, Lau KL, Sim J, Sum MY, Sim K. (2015) Duration of initial antidepressant treatment and subsequent relapse of major depression. J Clin Psychopharmacol 35:76–77. - PubMed
-
- Baldessarini RJ, Tondo L, Ghiani C, Lepri B. (2010) Discontinuation rate vs. recurrence risk following long-term antidepressant treatment in major depressive disorder patients. Am J Psychiatry 167:934–941. - PubMed
-
- Boulenger JP, Loft H, Florea I. (2012) Randomized clinical study of Lu-AA21004 in the prevention of relapse in patients with major depressive disorder. J Psychopharmacol 26:1408–1416. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical